期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Enhancing cancer immunotherapy:Nanotechnology-mediated immunotherapy overcoming immunosuppression
1
作者 Yunna Chen Qianqian Zhou +4 位作者 zongfang jia Nuo Cheng Sheng Zhang Weidong Chen Lei Wang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第9期3834-3854,共21页
Immunotherapy is an important cancer treatment method that offers hope for curing cancer patients.While immunotherapy has achieved initial success,a major obstacle to its widespread adoption is the inability to benefi... Immunotherapy is an important cancer treatment method that offers hope for curing cancer patients.While immunotherapy has achieved initial success,a major obstacle to its widespread adoption is the inability to benefit the majority of patients.The success or failure of immunotherapy is closely linked to the tumor’s immune microenvironment.Recently,there has been significant attention on strategies to regulate the tumor immune microenvironment in order to stimulate anti-tumor immune responses in cancer immunotherapy.The distinctive physical properties and design flexibility of nanomedicines have been extensively utilized to target immune cells(including tumor-associated macrophages(TAMs),T cells,myeloid-derived suppressor cells(MDSCs),and tumor-associated fibroblasts(TAFs)),offering promising advancements in cancer immunotherapy.In this article,we have reviewed treatment strategies aimed at targeting various immune cells to regulate the tumor immune microenvironment.The focus is on cancer immunotherapy models that are based on nanomedicines,with the goal of inducing or enhancing anti-tumor immune responses to improve immunotherapy.It is worth noting that combining cancer immunotherapy with other treatments,such as chemotherapy,radiotherapy,and photodynamic therapy,can maximize the therapeutic effects.Finally,we have identified the challenges that nanotechnology-mediated immunotherapy needs to overcome in order to design more effective nanosystems. 展开更多
关键词 IMMUNOTHERAPY NANOMEDICINE Tumor immunosuppressive microenvironment Cancer T cells Immunogenic cell death Immune checkpoint inhibitors Extracellular matrix
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部